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Objective: To develop a sensitive and speciﬁc in situ assay
for detecting HBV ccc DNA in biopsy specimens, to detect
intrahepatic in situ HBV ccc DNA of patients with liver
transplantation and to explore its clinical signiﬁcance.
Methods: Intrahepatic in situ ccc DNA and HBsAg, HBcAg,
pre-S1 in liver biopsy specimens of 25 patients with HBV
re-infection and 10 patients without HBV re-infection after
liver transplantation were detected by in situ polymerase
chain reaction (in situ PCR) and immunohistochemistry,
respectively.
Results: In all 35 cases detected by in situ PCR, 22 showed
HBV ccc DNA positive (62.9%). Positive signal presented as
purple blue block or granules located in affected hepatocyte
nuclei rather than cytoplasm or membrane. The positive
rate of ccc DNA in HBV re-infection group was greatly higher
than that in control group (84% vs 10%, P < 0.001). Detection
of HBV ccc DNA and HBcAg in liver biopsy specimens had
shown high consistency (kappa = 0.755, P < 0.001).
Conclusions: The expression of HBV ccc DNA in liver biopsy
specimens from the patients after liver transplantation may
close associated with HBV re-infection.
